Tanya Eadie

Tanya Eadie joined the Speech and Hearing Sciences faculty as an Assistant Professor in the fall of 2003, became an Associate Professor in 2009, and a Professor in 2015. She also is an adjunct Professor in the Department of Otolaryngology-Head and Neck Surgery. Dr. Eadie received both her Master's of Science in Communicative Disorders and her Ph.D. in Rehabilitation Sciences from the University of Western Ontario, in London, Ontario, Canada. Concomitant with her doctoral work, Dr. Eadie worked clinically as a speech-language pathologist for three years. She has served on several ad hoc committees related to clinical assessment in voice disorders for ASHA and is a past editor (speech section) for the Journal of Speech, Language, and Hearing Research. She has published over 70 peer-reviewed articles and has current and past funding from the National Institutes of Health (NIH) investigating clinical outcomes related to communication and voice disorders. In 2012, Dr. Eadie and her colleagues Drs. Carolyn Baylor, Kathryn Yorkston, Michael Burns, and Deanna Britton received the editor’s award from the American Journal of Speech-Language Pathology (Baylor et al., 2011). In the fall of 2015, Dr. Eadie was awarded Fellowship of the American Speech-Language-Hearing Association. 

The field of speech-language pathology recognizes the validity of comprehensive evaluation and treatment of communication disorders. This is reflected in ASHA's adoption of the International Classification of Functioning, Disability and Health (ICF) as the framework for the Scope of Practice in Speech-Language Pathology (ASHA, 2001). As such, Dr. Eadie's long-term goals are to develop a clinical evaluative protocol by which clinicians can more effectively and accurately report the degree of vocal impairment using physiologic, acoustic, and auditory-perceptual measures. In addition, she hopes to continue to expand upon the current clinical database addressing the degree of impact on daily voice activity and communicative participation as affected by various types of voice disorders, including those treated for head and neck cancer.